DAPSONE
- Product NDC
- 59651-666
- 11-digit product format
- 596510666
- Labeler code
- 59651
- Product ID
- 59651-666_83966a34-02d4-4794-bc2b-3e612b121973
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- DAPSONE
- Dosage form
- GEL
- Route
- TOPICAL
- Labeler
- Aurobindo Pharma Limited
- Application
- ANDA218457
- Marketing category
- ANDA
- Marketing start
- 2025-04-04
- Substance
- DAPSONE
- Active strength
- 50 mg/g
- Pharmacologic classes
- Sulfone [EPC], Sulfones [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 8W5C518302 | DAPSONE | 80-08-0 | DAPSONE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 59651-666-60 | 59651066660 | 1 TUBE in 1 CARTON (59651-666-60) / 60 g in 1 TUBE | 1 tube | 2025-04-04 | No | No | Historical |
| 59651-666-90 | 59651066690 | 1 TUBE in 1 CARTON (59651-666-90) / 90 g in 1 TUBE | 1 tube | 2025-04-04 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| DAPSONE | Aurobindo Pharma Limited | APL HEALTHCARE LIMITED | 2025-05-30 | Human Prescription Drug Label | 2 |